Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

ALX Oncology Holdings Inc. ALXO

Healthcare  —  Biotechnology
1.31 (0.05) (3.68%) as of 25 Sep
Market cap
$187.4M
P/E
0.0×
Insider Buys (last 12m)
Insider Buys alert about insiders buying in the last 12 month
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K
Quarterly (Descending) Quarterly (Ascending) Annual (Descending) Annual (Ascending) TTM (Descending) TTM (Ascending)
Download Excel — free account
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17
P/E ratio — — — — — 0.00 0.00 0.00 —
P/S ratio — — — — — 653.57 25.44 25.44 —
P/FCF ratio — — — — — 0.00 0.00 0.00 —
P/Operating CF — — — — — (117.03) (15.41) (15.41) —
P/B ratio — — — — — 3.71 0.00 0.00 —
Price to Tangible BV — — — — — 3.71 0.00 0.00 —
EV/Sales — — — — — 477.83 0.67 0.67 —
EV/EBITDA — — — — — 0.00 0.00 0.00 —
EV/Operating CF — — — — — (30.43) (0.12) (0.12) —
EV/FCF — — — — — (30.40) (0.12) (0.12) —
Quick Ratio 1.82 6.91 5.08 9.43 23.78 69.99 1.92 4.91 —
Current Ratio 2.07 7.26 5.24 9.57 24.00 70.28 1.97 5.45 —
Net Debt/EBITDA 0.34 0.81 0.99 2.00 4.32 10.09 0.19 0.62 —
Debt/Assets 16.51% 6.70% 3.97% 3.40% 0.68% 0.00% 50.78% 0.00% 0.00%
Debt/Equity 0.38 0.09 0.05 0.04 0.01 0.00 (0.08) 0.00 —
Asset Turnover 0.00 0.00 0.00 0.00 0.00 0.01 0.90 0.00 —
Operating CF/Net income 0.83 0.90 0.81 0.72 0.82 0.75 0.61 0.76 —
Capex/Depreciation 0.83 0.13 0.24 2.58 (96.53) (0.05) (0.80) (1.52) —
Interest Coverage 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 —
ROE (145.70%) (88.91%) (70.97%) (39.42%) (21.05%) (28.36%) 38.02% 28.43% —
ROA (98.34%) (69.10%) (58.58%) (35.97%) (20.45%) (22.81%) (435.95%) 0.00% —
ROIC 0.00% 0.00% (640.53%) (1,036.13%) (2,661.67%) 0.00% 0.00% 0.00% —
Return on Tangible Assets (371.50%) (113.55%) (102.92%) (50.09%) (23.67%) (11.85%) (409.34%) (187.30%) —
Average Days of Receivables — — — 0.00 — 0.00 40.79 164.58 —
Research and Development Expense of Revenue 0.00% 0.00% 0.00% 0.00% 0.00% 2,450.17% 339.99% 545.23% —
Selling, General and Administrative Expense of Revenue 0.00% 0.00% 0.00% 0.00% 0.00% 1,252.88% 69.08% 125.83% —
Intangible Assets out of Total Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Share Based Compensation of Revenue 0.00% 0.00% 0.00% 0.00% 0.00% 459.90% 6.19% 13.01% —
Graham Net Nets — — — — — 0.27 (0.91) (0.91) —
Graham Number — — — — — 0.00 0.00 0.00 —
Earnings Yield — — — — — (8.13%) (28.29%) (28.29%) —
Free Cash Flow Yield — — — — — (2.40%) (22.26%) (22.26%) —
Revenue per Share 0.00 0.00 0.00 0.00 0.00 0.06 1.56 0.75 —
Operating CF per Share (1.57) (2.34) (3.03) (2.19) (1.69) (2.07) (4.63) (4.79) —
Capex per Share 0.00 (0.01) (0.03) (0.04) (0.12) 0.00 (0.11) (0.24) —
Free Cash Flow per Share (1.57) (2.35) (3.06) (2.23) (1.81) (2.07) (4.75) (5.03) —
Cash per Share 0.83 2.45 4.25 6.54 9.02 23.49 2.93 3.00 —
Shareholders Equity per Share 0.48 2.18 4.41 6.47 9.01 23.25 (22.96) 0.00 —
Interest Debt per Share 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 —
Book value per Share 0.48 2.18 4.41 6.47 9.01 23.25 (22.96) 0.00 —
Free Cash Flow (84.35) (122.36) (131.64) (90.65) (73.02) (38.32) (14.60) (13.84) —
Working Capital 26.17 115.85 152.66 242.64 351.72 429.79 4.83 8.34 —
Capital Expenditures (0.21) (0.45) (1.27) (1.43) (4.92) (0.03) (0.35) (0.65) —
Net Current Asset Value 17.66 100.20 135.82 227.94 349.89 429.78 (71.51) 10.21 —
EV/EBIT — — — — — 0.00 0.00 0.00 —
Capex to Sales 0.00 0.00 0.00 0.00 0.00 0.03 0.07 0.32 —
Net Profit Margin 0.00% 0.00% 0.00% 0.00% 0.00% (4,309.81%) (485.22%) (841.90%) —
Price to Operating Income — — — — — 0.00 0.00 0.00 —
Other line items
Depreciation/Fixed assets (0.21) (1.21) (1.50) (0.14) 0.06 11.98 0.51 0.45 —
Cash ROIC (105.99%) (49.67%) (35.06%) (17.24%) (9.46%) (4.44%) 26.88% (171.22%) —
Accounts Receivable Turnover — — — 0.00 — 0.00 6.53 2.82 —
Accounts Payable Turnover 0.00 0.00 0.00 0.25 0.39 0.57 1.96 0.85 —
Inventory Turnover — — — 0.00 0.00 0.00 0.00 0.00 —
Average Days of Payables 0.00 0.00 0.00 2,009.99 1,866.66 1.36 313.77 135.32 —
Days of Inventory on Hand — — — 0.00 0.00 0.00 0.00 0.00 —
Average Receivables — — — 0.77 — — 0.73 0.73 —
Average Payables 4.71 6.54 8.33 5.92 1.88 1.88 2.22 2.22 —
Average Assets 103.41 195.16 274.52 343.34 408.12 223.37 5.34 0.00 —
Average Common Equity 69.80 151.67 226.59 313.26 396.45 179.60 (61.21) (61.21) —

Fold the line items

Columns are period end dates